Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Encouraging phase IIb results for antiparkinsonian patch

Feb. 13, 1997

Alza obtains rights to opioid analgesic and licenses the product to Knoll

Feb. 13, 1997

Potential cognition-enhancing agent described by Rotta

Feb. 12, 1997

Servier describes 5-HT3 agonist with additionial antagonist-like properties

Feb. 12, 1997

Cephalon and Chiron seek FDA approval for rhIGF-1

Feb. 12, 1997

Neurotrophic rotamase inhibitors described by Guilford

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Positive phase III trials results for citicoline

Feb. 11, 1997

Essential fatty acids in schizophrenia

Feb. 11, 1997

U.S. researchers report significant advance in gene therapy for hearing disorders

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...